Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

50
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
50
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

150
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
150
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

149
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
149
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

25
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
25
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

260
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
260
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

196
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
196

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of hub genes involved in early-onset schizophrenia: from genetic susceptibility to predicted regulated gene expression.

Molecular psychiatry·2026
Same author

Dysregulated miRNAs and downstream gene expression associated with poor treatment response in first-episode psychosis.

Brain, behavior, & immunity - health·2026
Same author

Family-Oriented and Individual-Oriented Lived Experiences in the Narrative Descriptions of Sibling Dyads with Parents Diagnosed with Bipolar Disorder.

Issues in mental health nursing·2026
Same author

Using Wearable Device and Machine Learning to Predict Mood Symptoms in Bipolar Disorder: Development and Usability Study.

JMIR medical informatics·2025
Same author

Successful antipsychotic dose tapering leading to better cognition in patients with remitted psychosis: Results of Guided Antipsychotic Reduction to Reach Minimum Effective Dose (GARMED) trial.

Psychological medicine·2025
Same author

Temporal imprecision and its dynamics in schizophrenia.

Translational psychiatry·2025

Related Experiment Video

Updated: Jul 14, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.6K

Electroconvulsive therapy for treatment-resistant depression.

Ming H Hsieh1

  • 1Department of Psychiatry, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.

Progress in Brain Research
|October 8, 2023
PubMed
Summary
This summary is machine-generated.

Electroconvulsive therapy (ECT) is a highly effective treatment for severe depression, offering rapid response and remission. It should be considered earlier in treatment-resistant depression (TRD) based on individual patient factors, not as a last resort.

Keywords:
Brain-derived neurotrophic factorsElectroconvulsive therapyHippocampusMajor depressive disorderMeta-analysisNeurostimulationRepetitive transcranial magnetic stimulationTreatment-resistant depression

More Related Videos

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.1K
Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.4K

Related Experiment Videos

Last Updated: Jul 14, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.6K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.1K
Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.4K

Area of Science:

  • Psychiatry
  • Neuroscience
  • Clinical Medicine

Background:

  • Electroconvulsive therapy (ECT) is the oldest brain stimulation procedure in psychiatry.
  • ECT is crucial for managing treatment-resistant depression (TRD), severe, and life-threatening depression.
  • ECT is considered a cost-effective treatment for severe TRD.

Purpose of the Study:

  • To review essential studies, meta-analyses, and guidelines on ECT for TRD.
  • To explore the clinical role of ECT compared to other neurostimulation treatments like repetitive transcranial magnetic stimulation (rTMS).
  • To enhance understanding of ECT's mechanisms of action in major depressive disorder (MDD).

Main Methods:

  • Review of existing literature including studies, meta-analyses, and expert guidelines.
  • Comparative analysis of ECT with other neurostimulation techniques.
  • Exploration of neurobiological research on ECT's mechanisms.

Main Results:

  • ECT demonstrates rapid response and remission in a majority of patients with resistant depression.
  • ECT is a primary treatment choice for severe, incapacitating forms of TRD.
  • Understanding ECT's neurobiological effects can improve patient care and understanding of MDD.

Conclusions:

  • ECT should not be a treatment of last resort; its application should be individualized.
  • ECT remains a standard and effective component of modern psychiatric medicine.
  • A more careful and thoughtful application of ECT is recommended for optimal patient outcomes.